Actively Recruiting
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
Led by Lund University Hospital · Updated on 2025-03-10
120
Participants Needed
1
Research Sites
312 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A translational study for identification of prognostic and treatment-predictive biomarkers in Mycosis fungoides and Sézary syndrome.
CONDITIONS
Official Title
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18-100 years
- Histologically confirmed Mycosis fungoides or Sezary syndrome stages I-IV according to WHO/EORTC classification
- WHO performance status between 0 and 3
- No psychiatric illness or condition interfering with understanding study requirements
- Written informed consent according to ICH/GCP and Swedish regulations
- No specific routine laboratory data required
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Lund University Hospital
Lund, Sweden, SE-221 85
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here